Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
14.67
-0.04 (-0.27%)
At close: Jul 25, 2025, 4:00 PM
15.00
+0.33 (2.25%)
After-hours: Jul 25, 2025, 7:03 PM EDT
Dr. Reddy's Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
334,260 | 325,535 | 279,164 | 245,879 | 214,391 | 189,722 | Upgrade | |
Revenue Growth (YoY) | 15.86% | 16.61% | 13.54% | 14.69% | 13.00% | 8.66% | Upgrade |
Cost of Revenue | 141,549 | 135,107 | 115,557 | 106,536 | 100,551 | 86,645 | Upgrade |
Gross Profit | 192,711 | 190,428 | 163,607 | 139,343 | 113,840 | 103,077 | Upgrade |
Selling, General & Admin | 95,809 | 92,853 | 76,921 | 68,026 | 62,081 | 54,650 | Upgrade |
Research & Development | 27,431 | 27,380 | 22,873 | 19,381 | 17,482 | 16,541 | Upgrade |
Other Operating Expenses | -3,162 | -2,836 | -1,775 | -1,480 | -1,642 | -1,024 | Upgrade |
Operating Expenses | 120,078 | 117,397 | 98,019 | 85,927 | 77,921 | 70,167 | Upgrade |
Operating Income | 72,633 | 73,031 | 65,588 | 53,416 | 35,919 | 32,910 | Upgrade |
Interest Expense | -3,061 | -2,829 | -1,711 | -1,428 | -958 | -970 | Upgrade |
Interest & Investment Income | 3,061 | 2,677 | 2,278 | 1,180 | 965 | 826 | Upgrade |
Earnings From Equity Investments | 160 | 217 | 147 | 370 | 703 | 480 | Upgrade |
Currency Exchange Gain (Loss) | 2,064 | 1,322 | 278 | 2,225 | 1,835 | 1,240 | Upgrade |
Other Non Operating Income (Expenses) | 3,554 | 3,554 | 3,149 | 876 | 277 | 557 | Upgrade |
EBT Excluding Unusual Items | 78,411 | 77,972 | 69,729 | 56,639 | 38,741 | 35,043 | Upgrade |
Merger & Restructuring Charges | -1,017 | -1,017 | -280 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -161 | - | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 1,465 | 1,522 | 900 | -1,211 | 1,119 | -42 | Upgrade |
Asset Writedown | -1,688 | -1,693 | -3 | -699 | -7,562 | -8,588 | Upgrade |
Legal Settlements | - | - | 1,524 | 5,638 | - | - | Upgrade |
Pretax Income | 77,010 | 76,784 | 71,870 | 60,367 | 32,298 | 26,413 | Upgrade |
Income Tax Expense | 19,589 | 19,539 | 16,186 | 15,300 | 8,730 | 9,175 | Upgrade |
Earnings From Continuing Operations | 57,421 | 57,245 | 55,684 | 45,067 | 23,568 | 17,238 | Upgrade |
Minority Interest in Earnings | -619 | -701 | - | - | - | - | Upgrade |
Net Income | 56,802 | 56,544 | 55,684 | 45,067 | 23,568 | 17,238 | Upgrade |
Net Income to Common | 56,802 | 56,544 | 55,684 | 45,067 | 23,568 | 17,238 | Upgrade |
Net Income Growth | 2.20% | 1.54% | 23.56% | 91.22% | 36.72% | -11.59% | Upgrade |
Shares Outstanding (Basic) | 833 | 833 | 832 | 830 | 829 | 829 | Upgrade |
Shares Outstanding (Diluted) | 834 | 834 | 834 | 832 | 832 | 832 | Upgrade |
Shares Change (YoY) | 0.01% | 0.08% | 0.19% | 0.03% | 0.01% | 0.14% | Upgrade |
EPS (Basic) | 68.20 | 67.88 | 66.93 | 54.29 | 28.42 | 20.79 | Upgrade |
EPS (Diluted) | 68.11 | 67.78 | 66.80 | 54.17 | 28.34 | 20.73 | Upgrade |
EPS Growth | 2.20% | 1.47% | 23.32% | 91.16% | 36.70% | -11.71% | Upgrade |
Free Cash Flow | 23,306 | 18,924 | 29,030 | 47,552 | 13,448 | 25,962 | Upgrade |
Free Cash Flow Per Share | 27.95 | 22.69 | 34.83 | 57.16 | 16.17 | 31.22 | Upgrade |
Dividend Per Share | 8.000 | 8.000 | 8.000 | 8.000 | 6.000 | 5.000 | Upgrade |
Dividend Growth | - | - | - | 33.33% | 20.00% | - | Upgrade |
Gross Margin | 57.65% | 58.50% | 58.61% | 56.67% | 53.10% | 54.33% | Upgrade |
Operating Margin | 21.73% | 22.43% | 23.49% | 21.73% | 16.75% | 17.35% | Upgrade |
Profit Margin | 16.99% | 17.37% | 19.95% | 18.33% | 10.99% | 9.09% | Upgrade |
Free Cash Flow Margin | 6.97% | 5.81% | 10.40% | 19.34% | 6.27% | 13.68% | Upgrade |
EBITDA | 89,397 | 88,840 | 79,286 | 66,052 | 47,743 | 45,706 | Upgrade |
EBITDA Margin | 26.75% | 27.29% | 28.40% | 26.86% | 22.27% | 24.09% | Upgrade |
D&A For EBITDA | 16,764 | 15,809 | 13,698 | 12,636 | 11,824 | 12,796 | Upgrade |
EBIT | 72,633 | 73,031 | 65,588 | 53,416 | 35,919 | 32,910 | Upgrade |
EBIT Margin | 21.73% | 22.43% | 23.49% | 21.73% | 16.75% | 17.35% | Upgrade |
Effective Tax Rate | 25.44% | 25.45% | 22.52% | 25.35% | 27.03% | 34.74% | Upgrade |
Updated Jul 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.